Soliqua vs Zepbound

Soliqua is a once-daily injection for type 2 diabetes that contains the active ingredient lixisenatide, made by Sanofi. Zepbound is a once-weekly injection for obesity and obstructive sleep apnea that contains the active ingredient tirzepatide, made by Eli Lilly. Both are given under the skin, but Soliqua is used for diabetes while Zepbound targets weight loss and sleep apnea.

AI summary of the sources below.